Precision medicine is an emerging field that looks at how a person’s unique genetic makeup can help determine what treatment might work best for that individual. Although many research studies have shown that precision medicine can lead to better health for some patients, very few of these research studies have looked at precision medicine specifically for African Americans.

The African American Cardiovascular Pharmacogenomics Consortium or ACCOuNT is a group of doctors, researchers, community leaders, and patients whose goal is to ensure that all people benefit fully from precision medicine.

Learn More

THREE MAIN GOALS


discovery

DISCOVERY

Search for genetic variations in African Americans that may affect how a person responds to a medication.

translation

TRANSLATION

Develop recommendations based on genetic variation that doctors can use when prescribing medications to patients.

 

dissemination 1
DISSEMINATION

Share information about precision medicine and pharmacogenomic research with patients and communities.

LEADERSHIP


Minoli Perera.png Minoli Perera, PharmD, PhD
Principal Investigator

meltzer David Meltzer, MD, PhD
Principal Investigator
Miller

Doriane Miller, MD
Core Lead

robert-grossman-print-2013Robert Grossman, PhD
Core Lead
20100729-o'donnell-peter-physicianportraitPeter H. O’Donnell, MD
Project Lead

IN THE NEWS


 

Precision Medicine for All

Precision medicine is an emerging field that looks at how a person’s unique genetic makeup can help determine what treatment might work best for that individual. Although many research studies have shown that precision medicine can lead to better health for some patients, very few of these research studies have looked at precision medicine specifically for African Americans.

The African American Cardiovascular Pharmacogenomics Consortium or ACCOuNT is a group of doctors, researchers, community leaders, and patients whose goal is to ensure that all people benefit fully from precision medicine.

Learn More

THREE MAIN GOALS


discovery

DISCOVERY

Search for genetic variations in African Americans that may affect how a person responds to a medication.

translation

TRANSLATION

Develop recommendations based on genetic variation that doctors can use when prescribing medications to patients.

 

dissemination 1
DISSEMINATION

Share information about precision medicine and pharmacogenomic research with patients and communities.

LEADERSHIP


Minoli Perera.png Minoli Perera, PharmD, PhD
Principal Investigator

meltzer David Meltzer, MD, PhD
Principal Investigator
Miller

Doriane Miller, MD
Core Lead

robert-grossman-print-2013Robert Grossman, PhD
Core Lead
20100729-o'donnell-peter-physicianportraitPeter H. O’Donnell, MD
Project Lead

IN THE NEWS


 

View All Features

IN THE NEWS

We recently had the 2019 Annual ACCOuNT meeting at Northwestern Pritzker School of Law on June 21. ACCOuNT 2019 Annual Meeting.

Continue Reading

Two ACCOuNT projects were presented at The International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne which took place July 6-10. Kaitlin Garofano, Ph.D. student at George Washington University in Molecular Medicine, presenting the “Platelet mRNA splicing landscape and its effect on platelet activity: An ACCOuNT consortium study” Minoli Perera, PharmD, Ph.D., presented the… Read More

Continue Reading

Congratulations to the ACCOuNT team members who presented at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting in Washington, DC, from March 13-16, 2019.

Continue Reading

Are you interested in participating in a study?

Fill out this form